Micro-invasive glaucoma surgery: current perspectives and future directions

被引:453
作者
Saheb, Hady [1 ,2 ]
Ahmed, Iqbal Ike K. [2 ,3 ]
机构
[1] McGill Univ, Dept Ophthalmol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
[2] Credit Valley Eyecare, Mississauga, ON, Canada
[3] Univ Toronto, Depart Dept Ophthalmol & Vis Sci, Toronto, ON, Canada
关键词
Ab interno glaucoma surgery; micro-invasive glaucoma surgery; novel glaucoma procedures; OPEN-ANGLE GLAUCOMA; COST-EFFECTIVENESS; TRABECULAR MICROBYPASS; LASER TRABECULOPLASTY; OCULAR HYPERTENSION; OUTFLOW PATHWAY; PERFUSION; STENT;
D O I
10.1097/ICU.0b013e32834ff1e7
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose of review There is an increasing interest and availability of micro-invasive glaucoma surgery (MIGS) procedures. It is important that this increase is supported by sound, peer-reviewed evidence. This article will define MIGS, review relevant publications in the period of annual review and discuss future directions. Recent findings The results of the pivotal trial comparing a trabecular micro-bypass stent (iStent, Glaukos Corporation, Laguna Hills, CA, USA) combined with phacoemulsification to phacoemulsification alone showed a significantly higher percentage of patients with unmedicated intraocular pressure (IOP) < 21 mmHg, and a comparable safety profile. Initial results are published regarding a second-generation micro-bypass stent (iStent inject, Glaukos Corporation, Laguna Hills, CA, USA), a canalicular scaffold (Hydrus, Ivantis Inc., Irvine, CA, USA) and an ab interno suprachoroidal microstent (CyPass, Transcend Medical, Menlo Park, CA, USA), showing a decrease in mean postoperative IOP. Phaco-Trabectome (Ab interno trabeculectomy Trabectome, NeoMedix Inc., Tustin, CA, USA) was compared to phacotrabeculectomy and showed less IOP reduction, less postoperative complications, and a similar success rate. Similar success rates were found with the comparison of excimer laser trabeculostomy (ELT, AIDA, Glautec AG, Nurnberg, Germany) and selective laser trabeculoplasty. A number of publications review the importance of the location of implantable devices, intraoperative gonioscopy, cost-effectiveness and quality-of-life studies, and randomized clinical trials. Summary MIGS procedures offer reduction in IOP, decrease in dependence on glaucoma medications and an excellent safety profile. Their role within our glaucoma treatment algorithm continues to be clarified and differs from the role of more invasive glaucoma surgeries such as trabeculectomy or glaucoma drainage devices.
引用
收藏
页码:96 / 104
页数:9
相关论文
共 45 条
[1]  
[Anonymous], ASCRS SAN DIEG
[2]  
[Anonymous], AGS DAN POINT
[3]  
[Anonymous], AAO 2010
[4]  
[Anonymous], ARVO M ABSTR
[5]  
[Anonymous], EXP EYE RES
[6]  
[Anonymous], AM GLAUC SO IN PRESS
[7]  
[Anonymous], AGS 2012 NEW Y UNPUB
[8]  
[Anonymous], ASCRS 2011 CHIC AGS
[9]  
[Anonymous], ARVO FT LAUD
[10]  
[Anonymous], AAO 2011